Cidara Therapeutics
Cidara Therapeutics, a San Diego biotech, is advancing rezafungin acetate—a long‑acting echinocandin antifungal—for invasive candidiasis, and its Cloudbreak platform for antiviral Fc‑conjugates targeting influenza, RSV and COVID‑19, with Phase 1/2a studies underway.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 38
- HQ: San Diego
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.